Platelet transfusion thresholds in according bleeding risk and the presence of bleeding. WHO = World Health Organization. “In practice, we see all too often [that] prophylactic transfusion of ...
OBJECTIVE: To determine the most effective, evidence-based approach to the use of platelet transfusions in patients with cancer. OUTCOMES: Outcomes of interest included prevention of morbidity and ...
Febrile responses to platelet transfusions are common but some can be life-threatening and the cause of these reactions is largely unknown. In June 23 Lancet, Richard Phipps and colleagues from ...
A preliminary study published in this week's issue of THE LANCET suggests a possible explanation for the biological process responsible for inducing fever and related symptoms after the transfusion of ...
Myelodysplastic syndromes (MDS) can damage bone marrow, lowering red blood cells and platelets. Transfusions replace missing cells to manage anemia or thrombocytopenia. Up to 9 in 10 people with MDS ...
Background: Transfusion-dependent bone marrow transplant recipients are routinely transfused with ABO group and RhD-compatible blood components. However, because of the scarcity of RhD-negative blood ...
The American Red Cross urges donors to give blood or platelets to help hospitals and transfusion centers stay prepared to ...
To provide evidence-based guidance on the use of platelet transfusion in people with cancer. This guideline updates and replaces the previous ASCO platelet transfusion guideline published initially in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results